These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17229179)

  • 1. Lack of management of cardiovascular risk factors in type 2 diabetic patients.
    Yun KE; Park MJ; Park HS
    Int J Clin Pract; 2007 Jan; 61(1):39-44. PubMed ID: 17229179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes.
    Grant RW; Cagliero E; Murphy-Sheehy P; Singer DE; Nathan DM; Meigs JB
    Am J Med; 2002 Jun; 112(8):603-9. PubMed ID: 12034408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microalbuminuria Education Medication and Optimisation (MEMO) study: 4 years follow-up of multifactorial intervention in high-risk individuals with type 2 diabetes.
    Crasto W; Morrison AE; Gray LJ; John E; Jarvis J; Brela J; Khunti K; Troughton J; Lawrence IG; McNally PG; Davies MJ
    Diabet Med; 2020 Feb; 37(2):286-297. PubMed ID: 31505051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
    Jerums G; MacIsaac RJ
    Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?
    George PB; Tobin KJ; Corpus RA; Devlin WH; O'Neill WW
    Am Heart J; 2001 Nov; 142(5):857-63. PubMed ID: 11685175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How well are hypertension and albuminuria treated in type II diabetic patients?
    Boero R; Prodi E; Elia F; Porta L; Martelli S; Ferraro L; Quarello F
    J Hum Hypertens; 2003 Jun; 17(6):413-8. PubMed ID: 12764404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HEMOGLOBIN A1C, BLOOD PRESSURE, AND LDL-CHOLESTEROL CONTROL AMONG HISPANIC/LATINO ADULTS WITH DIABETES: RESULTS FROM THE HISPANIC COMMUNITY HEALTH STUDY/STUDY OF LATINOS (HCHS/SOL).
    Casagrande SS; Aviles-Santa L; Corsino L; Daviglus ML; Gallo LC; Espinoza Giacinto RA; Llabre MM; Reina SA; Savage PJ; Schneiderman N; Talavera GA; Cowie CC
    Endocr Pract; 2017 Oct; 23(10):1232-1253. PubMed ID: 28816530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive.
    Shrivastava R; Khan A; Jeevanantham V; Nautiyal A; Garg P; Reddy PC
    South Med J; 2008 Jun; 101(6):606-11. PubMed ID: 18475221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis.
    Tu ST; Chang SJ; Chen JF; Tien KJ; Hsiao JY; Chen HC; Hsieh MC
    Arch Intern Med; 2010 Jan; 170(2):155-61. PubMed ID: 20101010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated levels of plasma von Willebrand factor and the risk of macro- and microvascular disease in type 2 diabetic patients with microalbuminuria.
    Gaede P; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2001 Oct; 16(10):2028-33. PubMed ID: 11572892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
    Bertoni AG; Clark JM; Feeney P; Yanovski SZ; Bantle J; Montgomery B; Safford MM; Herman WH; Haffner S;
    J Diabetes Complications; 2008; 22(1):1-9. PubMed ID: 18191071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of control.
    Bergenstal RM; Nag SS; Reusch JE; Sajjan SG; Alexander CM
    Endocr Pract; 2005; 11(3):172-9. PubMed ID: 16239203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an Electronic Software "Prompt" With Health Care Professional Training on Cardiovascular and Renal Complications in a Multiethnic Population With Type 2 Diabetes and Microalbuminuria (the GP-Prompt Study): Results of a Pragmatic Cluster-Randomized Trial.
    Willis A; Crasto W; Gray LJ; Dallosso H; Waheed G; Davies M; Seidu S; Khunti K
    Diabetes Care; 2020 Aug; 43(8):1893-1901. PubMed ID: 32430457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.
    Zhao XH; Xu ZR; Zhang Q; Gu HF; Yang YM
    J Zhejiang Univ Sci B; 2012 May; 13(5):378-85. PubMed ID: 22556176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.